Gujarat Terce Laboratories (BOM:524314) Net Income From Continuing Operations : ₹5.0 Mil (TTM As of Dec. 2023)

View and export this data going back to 1994. Start your Free Trial

What is Gujarat Terce Laboratories Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Gujarat Terce Laboratories's net income from continuing operations for the three months ended in Dec. 2023 was ₹6.7 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Dec. 2023 was ₹5.0 Mil.

Gujarat Terce Laboratories Net Income From Continuing Operations Historical Data

The historical data trend for Gujarat Terce Laboratories's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gujarat Terce Laboratories Net Income From Continuing Operations Chart

Gujarat Terce Laboratories Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Net Income From Continuing Operations

Get a 7-Day Free Trial

3.46

4.36

-25.20

7.47

-28.94

Gujarat Terce Laboratories Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Net Income From Continuing Operations	Get a 7-Day Free Trial															-0.03	8.03	-13.08	3.35	6.73

Gujarat Terce Laboratories Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹5.0 Mil.

Gujarat Terce Laboratories (BOM:524314) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gujarat Terce Laboratories Ltd (BOM:524314) » Definitions » Net Income From Continuing Operations

Traded in Other Exchanges

N/A

Address

Near Shivalik High-Street,, D/801 & 802,The First,, Behind Keshavbaug Party Plot,, Vastrapur,, Ahmedabad, GJ, IND, 380015

Website

https://www.gujaratterce.in

Gujarat Terce Laboratories Ltd is an India company having business in the medical and pharmaceutical preparations. It is engaged in the manufacturing of tablets, capsules, and syrup and injection. It offers branded as well as generic formulations covering different therapeutic areas such as antibiotics, respiratory, nutraceuticals, gastrointestinal, anti-fungal, and many more. Some of the main brands are Acolate, Tynol, DFS, Resplash , Aziter and others.

Gujarat Terce Laboratories (BOM:524314) Headlines

No Headlines